Mechanistically, higher adiposity increases the concentration of circulating pro-inflammatory markers which may lead to insulin resistance, simultaneously decreasing the levels of insulin-like growth factor binding-protein 1 (IGFBP-1) and increasing the bioavailability of IGF-1 [2]. The gene discussed is IGFBP1; the disease is Insulin resistance.